SBI PSU Fund vs Tata India Pharma & Healthcare Fund
Sectoral/ Thematic · Direct Plan – Growth · Compared on official AMFI NAV data · NAVs as of 13-Jul-2026
| Metric | SBI PSU Fund | Tata India Pharma & Healthcare Fund |
|---|---|---|
| Latest NAV | ₹38.5 | ₹38.94 |
| 1-Year Return | +7.39% | +11.09% |
| 3-Year Return (CAGR) | +27.49% | +24.84% |
| 5-Year Return (CAGR) | N/A | N/A |
| Volatility (1Y, annualised) | 14.7% | 11.9% |
| Max Drawdown | −24.1% | −16.8% |
| Fund House | SBI Mutual Fund | Tata Mutual Fund |
Growth of ₹10,000
If you had invested ₹10,000 in each fund
Embed this chart on your site (free)
Copy this code into your website or blog. It stays up to date automatically.
<iframe src="https://moneydock.in/embed/fund-compare/sbi-psu-fund-vs-tata-india-pharma-and-healthcare-fund" width="100%" height="520" style="border:1px solid #e5e7eb;border-radius:12px;max-width:760px" title="SBI PSU Fund vs Tata India Pharma & Healthcare Fund by MoneyDock" loading="lazy"></iframe> <p style="font-size:12px">Powered by <a href="https://moneydock.in" target="_blank" rel="noopener">MoneyDock</a></p>
See the embed documentation for all widgets, sizing options and usage terms.
SBI PSU Fund vs Tata India Pharma & Healthcare Fund: which is better?
SBI PSU Fund and Tata India Pharma & Healthcare Fund are both sectoral/ thematic mutual funds (direct plan, growth option). This comparison uses each fund's official AMFI NAV history — the same daily data the fund houses publish — to compare returns, volatility and drawdowns side by side.
On 3-year returns (annualised), SBI PSU Fund leads with +27.49% against +24.84% — a gap of about 2.65 percentage points per year over that period.
Tata India Pharma & Healthcare Fund has been the steadier fund over the past year, with annualised volatility of 11.9% versus 14.7%. Looking at worst falls, SBI PSU Fund's deepest drawdown in the stored history is −24.1% against −16.8% for Tata India Pharma & Healthcare Fund.
Which fund suits you depends on your horizon and appetite for swings: the higher-return fund is only the better pick if you can hold through its rougher months. Use the ₹10,000 growth chart above to see how each fund actually behaved through market cycles, and consider consulting a SEBI-registered adviser before investing. This comparison is informational, not investment advice.
Key takeaways
- SBI PSU Fund has delivered higher 3-year returns (+27.49% vs +24.84%).
- Tata India Pharma & Healthcare Fund has shown lower volatility over the trailing year.
- Tata India Pharma & Healthcare Fund has had the shallower maximum drawdown (−16.8%).
Frequently Asked Questions
Which fund has given higher returns — SBI PSU Fund or Tata India Pharma & Healthcare Fund?
Over the past 3 year period, SBI PSU Fund has delivered higher returns: +27.49% versus +24.84% annualised. Past performance does not guarantee future results.
Which fund is less risky — SBI PSU Fund or Tata India Pharma & Healthcare Fund?
Based on the trailing year, Tata India Pharma & Healthcare Fund has shown lower day-to-day volatility (SBI PSU Fund: 14.7%, Tata India Pharma & Healthcare Fund: 11.9% annualised). Volatility and drawdowns describe past behaviour, not future safety — both funds carry the market risk of their category.
Can I invest in both SBI PSU Fund and Tata India Pharma & Healthcare Fund?
Yes — many investors split a SIP across two funds. If both funds are from the same category, remember they will hold overlapping stocks, so diversification benefits may be smaller than they appear. Check each scheme's portfolio before doubling up within one category.
More Sectoral/ Thematic comparisons
Returns, volatility and drawdowns are computed from official AMFI NAV history for direct-growth plans and may differ slightly from fund-house factsheets due to date conventions. Mutual fund investments are subject to market risks. This comparison is for informational purposes only — not investment advice.